White matter microstructure associated with anhedonia among individuals with bipolar disorders and high-risk for bipolar disorders

Carregando...
Imagem de Miniatura
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2022
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER
Autores
DIAZ, Alexandre Paim
FERNANDES, Brisa S.
TEIXEIRA, Antonio Lucio
MWANGI, Benson
HASAN, Khader M.
WU, Mon-Ju
SELVARAJ, Sudhakar
Citação
JOURNAL OF AFFECTIVE DISORDERS, v.300, p.91-98, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Anhedonia - a key symptom of depression - is highly associated with poorer outcomes and suicidal behavior. Alterations in the circuitry of reward-related brain regions have been robustly associated with anhedonia in unipolar depression, but not bipolar disorder (BD). We investigated white matter microstructures associated with anhedonia in participants with BD types I and II and first-degree relatives of patients with BD (BD-siblings). Methods: Eighty participants (BD types I and II: 56 [70%], and BD-siblings: 24 [30%]) underwent diffusion tensor imaging (DTI); Fractional anisotropy (FA) of different tracts were computed. Anhedonia was assessed using item 8, (""inability to feel"") of the MADRS scale. General linear models were used to compare the FA of different tracts in participants with and without anhedonia controlling for several clinical and demographic variables. Results: The mean age of the sample was 37 (+/- 11) years old, and 68.8% were female. Participants with anhedonia (32.5%) presented lower mean FA in the left uncinate fasciculus (UF) (p = 0.005), right temporal endings of the superior longitudinal fasciculus (SLFT) (p = 0.04), and in the left and right parietal endings of the superior longitudinal fasciculus (SLFP) (p = 0.003, and p = 0.04, respectively). Similar comparisons between participants with or without current depressive episodes and between participants with or without inner tension according to the MADRS did not show significant differences, specificity of the findings for anhedonia. Conclusions: Lower FA in the left UF and SLF are potential neuroimaging markers of anhedonia in individuals with BD and high-risk for BD.
Palavras-chave
Bipolar disorders, Neuroimaging, Anhedonia, Orbitofrontal cortex, Nucleus accumbens, Diffusion tensor imaging, Biomarker
Referências
  1. Alba-Ferrara LM, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00009
  2. Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011
  3. Ameli R, 2014, PEERJ, V2, DOI 10.7717/peerj.429
  4. Auerbach RP, 2019, JAMA PSYCHIAT, V76, P571, DOI 10.1001/jamapsychiatry.2018.4600
  5. Ballard ED, 2017, J AFFECT DISORDERS, V218, P195, DOI 10.1016/j.jad.2017.04.057
  6. Baydin S, 2016, OPER NEUROSURG, V12, P269, DOI 10.1227/NEU.0000000000001133
  7. Berridge KC, 2015, NEURON, V86, P646, DOI 10.1016/j.neuron.2015.02.018
  8. Bonanni L, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55080458
  9. Brodaty H, 2010, INT PSYCHOGERIATR, V22, P426, DOI 10.1017/S1041610209991335
  10. Cole J, 2012, BRIT J PSYCHIAT, V201, P33, DOI 10.1192/bjp.bp.111.100594
  11. Dillon DG, 2018, DEPRESS ANXIETY, V35, P440, DOI 10.1002/da.22734
  12. Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6
  13. Drysdale AT, 2017, NAT MED, V23, P28, DOI 10.1038/nm.4246
  14. Duarte JA, 2016, REV BRAS PSIQUIATR, V38, P167, DOI 10.1590/1516-4446-2015-1793
  15. Favre P, 2019, NEUROPSYCHOPHARMACOL, V44, P2285, DOI 10.1038/s41386-019-0485-6
  16. First, 1996, STRUCTURED CLIN INTE
  17. Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021
  18. Frazier JA, 2007, BIPOLAR DISORD, V9, P799, DOI 10.1111/j.1399-5618.2007.00482.x
  19. Gorwood Philip, 2008, Dialogues Clin Neurosci, V10, P291
  20. Gross DW, 2011, EPILEPSIA, V52, P32, DOI 10.1111/j.1528-1167.2011.03149.x
  21. Grover VPB, 2015, J CLIN EXP HEPATOL, V5, P246, DOI 10.1016/j.jceh.2015.08.001
  22. Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129
  23. Harnett NG, 2021, DEPRESS ANXIETY, V38, P79, DOI 10.1002/da.23104
  24. Hasan KM, 2009, BRAIN RES, V1276, P67, DOI 10.1016/j.brainres.2009.04.025
  25. Horan WP, 2006, SCHIZOPHRENIA BULL, V32, P259, DOI 10.1093/schbul/sbj009
  26. Husain M, 2018, NAT REV NEUROSCI, V19, P470, DOI 10.1038/s41583-018-0029-9
  27. Jiang WH, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2019.101989
  28. Kreilkamp BAK, 2017, NEUROIMAGE-CLIN, V14, P67, DOI 10.1016/j.nicl.2017.01.003
  29. Lyden H, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.21
  30. Madonna D, 2019, BRAZ J PSYCHIAT, V41, P336, DOI 10.1590/1516-4446-2018-0108
  31. McMakin DL, 2012, J AM ACAD CHILD PSY, V51, P404, DOI 10.1016/j.jaac.2012.01.011
  32. Melloni EMT, 2020, J AFFECT DISORDERS, V274, P1049, DOI 10.1016/j.jad.2020.05.146
  33. Meoded A., 2017, REFERENCE MODULE NEU
  34. MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382
  35. Mwangi B, 2013, NEUROIMAGE, V75, P58, DOI 10.1016/j.neuroimage.2013.02.055
  36. Nakajima R, 2020, BRAIN IMAGING BEHAV, V14, P2817, DOI 10.1007/s11682-019-00187-4
  37. Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087
  38. Pushkarskaya H, 2019, J PSYCHIATR RES, V109, P202, DOI 10.1016/j.jpsychires.2018.11.029
  39. Rizvi SJ, 2016, NEUROSCI BIOBEHAV R, V65, P21, DOI 10.1016/j.neubiorev.2016.03.004
  40. Robbins TW, 2016, SCIENCE, V351, P24, DOI 10.1126/science.aad9698
  41. Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267
  42. Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005
  43. Squarcina L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178089
  44. Vijayalaxmi, 2015, MUTAT RES-REV MUTAT, V764, P51, DOI 10.1016/j.mrrev.2015.02.002
  45. Vinckier F, 2017, EUR PSYCHIAT, V44, P1, DOI 10.1016/j.eurpsy.2017.02.485
  46. Von Der Heide RJ, 2013, BRAIN, V136, P1692, DOI 10.1093/brain/awt094
  47. WATSON D, 1995, J ABNORM PSYCHOL, V104, P3, DOI 10.1037/0021-843X.104.1.3
  48. Wei Q, 2020, J AFFECT DISORDERS, V264, P163, DOI 10.1016/j.jad.2019.11.120
  49. Wilcox CE, 2016, AM J PSYCHIAT, V173, P344, DOI 10.1176/appi.ajp.2015.15060710
  50. Xu E., 2021, J AFFECT DISORDERS, V297, P208
  51. Zhang B, 2016, BRAIN IMAGING BEHAV, V10, P920, DOI 10.1007/s11682-015-9457-6